Tag Archives: Accelerate Diagnostics

September 2022—BD and Accelerate Diagnostics announced a worldwide commercial collaboration agreement in which BD will offer Accelerate’s rapid testing solution for antibiotic resistance and susceptibility. Under the agreement, BD will market and sell the Accelerate Pheno system and Accelerate Arc module and associated test kits through its worldwide sales network in territories where products have regulatory approval or registration.

Aug. 17, 2022—BD and Accelerate Diagnostics announced a worldwide commercial collaboration agreement in which BD will offer Accelerate’s rapid testing solution for antibiotic resistance and susceptibility.

June 2022—Accelerate Diagnostics announced the release of new performance data on the Accelerate Arc module and blood culture kit.

March 28, 2022—Accelerate Diagnostics launched the Accelerate Arc system for rapid and accurate microbial identification of positive blood cultures.

May 2017—Accelerate Diagnostics announced that the FDA has granted the de novo request to market the Accelerate Pheno system and Accelerate PhenoTest BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples.